alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Teddrick BATISTE, petitioner, v. Lorie DAVIS, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

No. 18-7431.

Supreme Court of the United States

April 22, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
EXHIBIT 31.1

CERTIFICATION

I, Tom W. Ward, certify that:

1.   I have reviewed this 10-Q Report of Exabyte Corporation;

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)   Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

c)   Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

5.   The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Dated:  May 17, 2004

/s/  TOM W. WARD
I, Lee Cole, certify that:

1. I have reviewed this annual report on Form 10-KSB of Enhance Lifesciences
Inc;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this annual report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this annual
report (the "Evaluation Date"); and

c) presented in this annual report our conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):

a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6. The registrant's other certifying officers and I have indicated in this
annual report whether or not there were significant changes in internal controls
or in other factors that could significantly affect internal controls subsequent
to the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: November 17, 2003





 /s/ Lee Cole
-----------------------
Lee Cole
Chief Financial Officer
**Exhibit 31.2**
CERTIFICATION
I, Craig P. Keller, Chief Financial Officer of Philadelphia ConsolidatedHolding Corp, certify that:
1. I have reviewed this quarterly report on Form 10-Q of PhiladelphiaConsolidated Holding Corp. 2. Based on my knowledge, this report does not contain any untrue statementof a material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by thisreport; 3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows ofthe registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrantand have:
 (a) Designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made knownto us by others within those entities, particularly during theperiod in which this report is being prepared;  (b) Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures asof the end of the period covered by this report based on suchevaluation; and  (c) Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’s fourthfiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based onour most recent evaluation of internal control over financial reporting,to the registrant’s auditors and the audit committee of the registrant’sboard of directors (or persons performing the equivalent functions):
 (a) All significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reportingwhich are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financialinformation; and  (b) Any fraud, whether or not material, that involves managementor other employees who have a significant role in the registrant’sinternal control over financial reporting.      Signed: Craig P. Keller       Name: Craig P. KellerMay 7, 2004   Title: Chief Financial Officer
Keith Lamont TUTT, petitioner, v. UNITED STATES.

No. 18-5047.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
Marcel A. WALTON, petitioner, v. UNITED STATES.

No. 18-8698.

Supreme Court of the United States

April 29, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit denied.
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1460 Introduced in House (IH)]

106th CONGRESS
  1st Session
                                H. R. 1460

  To amend the Ysleta del Sur Pueblo and Alabama and Coushatta Indian 
Tribes of Texas Restoration Act to decrease the requisite blood quantum 
      required for membership in the Ysleta del Sur Pueblo tribe.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 15, 1999

  Mr. Reyes introduced the following bill; which was referred to the 
                         Committee on Resources

_______________________________________________________________________

                                 A BILL

 
  To amend the Ysleta del Sur Pueblo and Alabama and Coushatta Indian 
Tribes of Texas Restoration Act to decrease the requisite blood quantum 
      required for membership in the Ysleta del Sur Pueblo tribe.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. BLOOD QUANTUM REQUIRED FOR TRIBAL MEMBERSHIP DECREASED.

    Section 108(a)(2)(i) of the Ysleta del Sur Pueblo and Alabama and 
Coushatta Indian Tribes of Texas Restoration Act (25 U.S.C. 1300g-7) is 
amended by striking ``\1/8\'' and inserting ``\1/16\''.
                                 <all>
```
[Federal Register Volume 87, Number 88 (Friday, May 6, 2022)]
[Notices]
[Page 27174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-09711]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Career Development Program to Promote 
Diversity in Health Research.
    Date: June 10, 2022.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Sun Saret, Ph.D., Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6705 Rockledge Drive, Room 
208-S, Bethesda, MD 20892, (301) 435-0270, <a href="/cdn-cgi/l/email-protection#9ae9eff4b4e9fbe8ffeedaf4f3f2b4fdf5ec"><span class="__cf_email__" data-cfemail="88fbfde6a6fbe9faedfcc8e6e1e0a6efe7fe">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: May 2, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-09711 Filed 5-5-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Veronica HARTFIELD, et al., petitioners, v. EIGHTH JUDICIAL DISTRICT FOR NEVADA, CLARK COUNTY, et al.

No. 17-1661.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Supreme Court of Nevada denied.
Donovan GRANT, petitioner, v. UNITED STATES.

No. 18-6772.

Supreme Court of the United States

Feb. 25, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the First Circuit denied.
EXHIBIT 32

                                  CERTIFICATION
                           Pursuant to 18 U.S.C. 1350
                 (Section 906 of the Sarbanes-Oxley Act of 2002)

In connection with the annual report on form 10-K of Empire Global Corp.
(the "Company") for the year ended December 31, 2012, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), Michael
Ciavarella, as Chief Executive Officer and Chief Financial Officer of the
Company, hereby certifies, pursuant to 18 U.S.C. ss.1350, as adopted pursuant
to ss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.

Date: April 15, 2013                  By: /s/ Michael Ciavarella
                                         ---------------------------------------
                                         Michael Ciavarella
                                         Chief Executive Officer, and
                                         Chief Financial Officer

This certification accompanies each Report pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of ss.18
of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 87, Number 88 (Friday, May 6, 2022)]
[Notices]
[Page 27136]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-09904]


=======================================================================
-----------------------------------------------------------------------

CORPORATION FOR NATIONAL AND COMMUNITY SERVICE


Sunshine Act Meetings

    The Board of Directors of the Corporation for National and 
Community Service (operating as AmeriCorps) gives notice of the 
following meeting:

TIME AND DATE: Friday, May 13, 2022, 12:00 p.m.-2:00 p.m. (ET).

PLACE: Virtual, by Zoom and telephone.
    <bullet> To register for the meeting, please use this link: https://americorps.zoomgov.com/webinar/register/WN_hGYcFXb-TuqS8Kyfxbqfcg.
    <bullet> To participate by phone, call (833) 568-8864 (Toll Free).

STATUS: Open to the public.

MATTERS TO BE CONSIDERED: 

I. Election of a Chair
II. Board Member Introductory Remarks
III. Discussion on AmeriCorps 2022-2026 Strategic Plan and Strategic 
Learning and Evidence Plan
IV. CEO Report
V. Spotlight and Panel on American Rescue Plan Implementation
VI. Public Comment
VII. Chair's Closing Remarks and Adjournment

    Members of the public who would like to comment on the business of 
the Board may do so in writing or virtually. Submit written comments to 
<a href="/cdn-cgi/l/email-protection#cfada0aebdab8faca1bce1a8a0b9"><span class="__cf_email__" data-cfemail="5735383625331734392479303821">[email protected]</span></a> with the subject line: ``Comments for May 13, 2022 
AmeriCorps Board Meeting'' no later than 5:00 p.m. (ET) May 9, 2022. 
Individuals who would like to comment during the meeting will be given 
instructions for signing up when they join the meeting. Comments are 
requested to be limited to two minutes.
    AmeriCorps provides reasonable accommodation to individuals with 
disabilities, where needed.

CONTACT PERSON FOR MORE INFORMATION: Henry Hicks, by telephone: (202) 
606-6864 or by email: <a href="/cdn-cgi/l/email-protection#f99191909a928ab99a978ad79e968f"><span class="__cf_email__" data-cfemail="284040414b435b684b465b064f475e">[email protected]</span></a>.

     Dated: May 4, 2022.
Fernando Laguarda,
General Counsel.
[FR Doc. 2022-09904 Filed 5-4-22; 4:15 pm]
BILLING CODE 6050-28-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 99.1 

 

CERTIFICATION PURSUANT TO 

18 U.S.C. SECTION 1350 

AS ADOPTED PURSUANT TO 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

 

In connection with the Annual Report of Ascendant Solutions, Inc. (the “Company”) on Form 10-K for the period ending December31, 2002 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David E. Bowe, Chief Executive Officer, President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, asadopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that: 

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. 

 

/s/ David E.Bowe                                    

David E. Bowe 

Chief Executive Officer, President and 

Chief FinancialOfficer 

March 31, 2003 

 

A signed original of this written statement required by Section 906 has been provided to Ascendant Solutions, Inc. and willbe retained by Ascendant Solutions, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 19 - 0 63 8 STATE OF MONTANA,

Plaintiff and Appellee, v. KATHRYN ERIN ALM ,

Defendant and Appellant.

**ORDER** Upo n consideration of Appellant’s motion to voluntarily dismiss appeal and good cause appearing , IT IS HEREBY ORDERED that Appellant’s appeal in the above matter is hereby DISMISSED with prejudice.

Electronically signed by: Mike McGrath Chief Justice, Montana Supreme Court

October 2 2020

10/02/2020
Case Number: DA 19-0638
EMULEX CORPORATION, et al., petitioners, v. Gary VARJABEDIAN, et al.

No. 18-459.

Supreme Court of the United States

April 1, 2019.

Motion of the Solicitor General for leave to participate in oral argument as *amicus curiae* and for divided argument granted.
```

```

----

Updated November 18, 2011
**Exhibit31.1**

 

**CERTIFICATIONOF CHIEF EXECUTIVE OFFICER**

 

I, Arthur W. Zafiropoulo, certify that:

 

1. I have reviewed this quarterly report onForm 10-Q of Ultratech, Inc.;

 

2. Based on my knowledge, this report doesnot contain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the periodcovered by this report;

 

3. Based on my knowledge, the financialstatements, and other financial information included in this report, fairlypresent in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in thisreport;

 

4. The registrant’s other certifyingofficer(s) and I are responsible for establishing and maintaining disclosurecontrols and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

 

a) Designed such disclosurecontrols and procedures, or caused such disclosure controls and procedures tobe designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which thisreport is being prepared;

 

b) Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

 

c) Disclosed in this reportany change in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and

 

5. The registrant’s other certifyingofficer(s) and I have disclosed, based on our most recent evaluation ofinternal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing theequivalent functions):

 

a) All significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

 

b) Any fraud, whether or notmaterial, that involves management or other employees who have a significantrole in the registrant’s internal control over financial reporting.

 
| November 5, 2004 | /s/ Arthur W. Zafiropoulo |   |
|------------------|---------------------------|--------|
|             | Arthur W. Zafiropoulo     |
|             | Chief Executive Officer   |

 

 

 

----